Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Ra Capital Management, L.P. reported a 9.10% stake in Aclaris Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ra Capital Management, L.P. reported a 9.10% stake in Aclaris Therapeutics, Inc., 12,723,026 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.10%
- Shares
- 12,723,026
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.10% | 12,723,026 |
| Peter Kolchinsky | 9.10% | 12,723,026 |
| Rajeev Shah | 9.10% | 12,723,026 |
| RA Capital Healthcare Fund, L.P. | 9.10% | 12,723,026 |
Source
Related
- Aclaris Therapeutics, Inc.
- Ra Capital Management, L.P.
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Apr 7, 2026
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026
- Form 4 · Milano Vincent · Jun 8, 2026